Mylan Investors

As one of the world’s leading generics and specialty pharmaceutical companies, our products reach approximately 145 countries and territories. Our leading position in key global markets is based on a broad product portfolio, robust pipeline, approximately 30,000 workforce, wide range of dosage forms and delivery systems, large manufacturing capacity and dedication to quality and service.